000 | 01160 a2200313 4500 | ||
---|---|---|---|
005 | 20250514034213.0 | ||
264 | 0 | _c20021217 | |
008 | 200212s 0 0 eng d | ||
022 | _a1472-4472 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJardemark, Kent | |
245 | 0 | 0 |
_aDopamine D3 and D4 receptor antagonists in the treatment of schizophrenia. _h[electronic resource] |
260 |
_bCurrent opinion in investigational drugs (London, England : 2000) _cJan 2002 |
||
300 |
_a101-5 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBrain _xdrug effects |
650 | 0 | 4 |
_aDopamine Antagonists _xchemistry |
650 | 0 | 4 | _aDopamine D2 Receptor Antagonists |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aReceptors, Dopamine D2 _xbiosynthesis |
650 | 0 | 4 | _aReceptors, Dopamine D3 |
650 | 0 | 4 | _aReceptors, Dopamine D4 |
650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
700 | 1 | _aWadenberg, Marie-Louise | |
700 | 1 | _aGrillner, Pernilla | |
700 | 1 | _aSvensson, Torgny H | |
773 | 0 |
_tCurrent opinion in investigational drugs (London, England : 2000) _gvol. 3 _gno. 1 _gp. 101-5 |
|
999 |
_c11950177 _d11950177 |